Regenerative Medicine Fund

Regenerative Medicine Fund invests in the key sub-sectors in cell therapy and organ regeneration, including cell technology, bio-materials, manufacturing processes, organ transplantation skills and, equipment, consumables and AI platforms associated with organ regenerations.

Investment cases

​Iviva Medical, Boston: The leading R&D company focusing on solutions to late stage kidney failure


        ©2018 DM Capital Ltd. All rights reserved